COST

1,026.04

+1.58%↑

PG

163.23

+0.5%↑

KO

71.99

+0.52%↑

PM

170.34

+0.66%↑

PEP

131.96

+0.43%↑

COST

1,026.04

+1.58%↑

PG

163.23

+0.5%↑

KO

71.99

+0.52%↑

PM

170.34

+0.66%↑

PEP

131.96

+0.43%↑

COST

1,026.04

+1.58%↑

PG

163.23

+0.5%↑

KO

71.99

+0.52%↑

PM

170.34

+0.66%↑

PEP

131.96

+0.43%↑

COST

1,026.04

+1.58%↑

PG

163.23

+0.5%↑

KO

71.99

+0.52%↑

PM

170.34

+0.66%↑

PEP

131.96

+0.43%↑

COST

1,026.04

+1.58%↑

PG

163.23

+0.5%↑

KO

71.99

+0.52%↑

PM

170.34

+0.66%↑

PEP

131.96

+0.43%↑

Search

Hims & Hers Health Inc

Închisă

SectorConsumator defensiv

64.47 10.15

Rezumat

Modificarea prețului

24h

Curent

Minim

57.38

Maxim

64.77

Indicatori cheie

By Trading Economics

Venit

23M

49M

Vânzări

105M

586M

P/E

Medie Sector

81.191

42.52

EPS

0.2

Marjă de profit

8.444

Angajați

1,637

EBITDA

39M

58M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

-25.56% downside

Dividende

By Dow Jones

Următoarele câștiguri

4 aug. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

3.2B

12B

Deschiderea anterioară

54.32

Închiderea anterioară

64.47

Sentimentul știrilor

By Acuity

50%

50%

16 / 151 Clasament în Consumer defensive

Scor tehnic

By Trading Central

Încredere

Bullish Evidence

Hims & Hers Health Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

29 apr. 2025, 12:54 UTC

Principalele dinamici ale pieței

Hims & Hers Rallies After Novo Nordisk Deal on Wegovy

4 apr. 2025, 22:38 UTC

Acțiuni populare

Stocks to Watch: Eli Lilly, Novo Nordisk, Hims & Hers, Maxeon Solar Technologies

1 apr. 2025, 23:15 UTC

Principalele dinamici ale pieței

Hims & Hers Adds Eli Lilly's Zepbound in Expansion of Weight-Loss Offerings -- 2nd Update

25 feb. 2025, 15:33 UTC

Principalele dinamici ale pieței

Novo Nordisk Shares Rise as Hims & Hers to Stop Mimicking Weight-Loss Drugs

18 nov. 2024, 19:07 UTC

Principalele dinamici ale pieței

Hims & Hers Stock Climbs After Former Regulator Autor Joins Board

14 oct. 2024, 15:02 UTC

Principalele dinamici ale pieței

Hims & Hers Health Shares Jump After FDA Set to Reconsider Limits on Knockoff Weight-Loss Drugs

3 oct. 2024, 11:28 UTC

Principalele dinamici ale pieței

Hims & Hers Health Shares Fall After FDA Removes Eli Lilly Obesity Drugs From Shortage List

7 mai 2025, 13:56 UTC

Câștiguri

Novo Nordisk Stock Jumps After Earnings. Compounding Market's Growth Took it By Surprise -- Barrons.com

6 mai 2025, 14:24 UTC

Câștiguri

Hims & Hers Stock Is Higher After Earnings. The Sales Outlook Looks Low. -- Barrons.com

30 apr. 2025, 09:30 UTC

Top știri

Why New Wegovy Deals Won't Restore Novo's Obesity Lead -- Heard on the Street -- WSJ

2 apr. 2025, 16:53 UTC

Top știri

Hims & Hers Zepbound Offering Won't Bring Needed Sales Boom -- Analysis

19 mar. 2025, 15:54 UTC

Top știri

Sale of Ozempic Knockoffs Are Supposed to End Soon. Telehealth Companies Aren't Happy. -- WSJ

21 feb. 2025, 23:20 UTC

Câștiguri

These Stocks Moved the Most Today: UnitedHealth, Alibaba, Rivian, Celsius, Booking, Block, Akamai, Hims & Hers, and More -- Barrons.com

10 feb. 2025, 12:00 UTC

Top știri

Hims Super Bowl Ad Spotlights Weight-Loss Drug Copycats as Clock Ticks on Their Business -- Heard on the Street -- WSJ

19 dec. 2024, 17:16 UTC

Top știri

FDA Says Shortage of Eli Lilly's Zepbound is Over, But Gives Compounders a Grace Period -- Barrons.com

19 dec. 2024, 15:14 UTC

Top știri

Eli Lilly's Zepbound Shortage Is Officially Over, FDA Says -- Barrons.com

19 dec. 2024, 15:02 UTC

Top știri

The Zepbound Shortage Is Officially Over, FDA Says -- Barrons.com

16 dec. 2024, 13:47 UTC

Top știri

The Weight-Loss Drug Market Is Heading for a Reckoning This Week -- Barrons.com

16 dec. 2024, 07:00 UTC

Top știri

The Weight-Loss Drug Market Is Heading for a Reckoning This Week. What to Expect. -- Barrons.com

3 oct. 2024, 14:45 UTC

Top știri

Eli Lilly's Weight-Loss Drugs Are No Longer in Short Supply. Bad News for Hims & Hers. -- Barrons.com

3 oct. 2024, 13:12 UTC

Top știri

Eli Lilly's Weight-Loss Drugs No Longer in Shortage. Bad News for Hims & Hers. -- Barrons.com

3 oct. 2024, 11:45 UTC

Top știri

Update: Eli Lilly's Weight-Loss Drugs No Longer in Shortage. Bad News for Hims & Hers. -- Barrons.com

3 oct. 2024, 10:14 UTC

Top știri

Update: Eli Lilly's Weight-Loss Drugs No Longer In Shortage. It's Bad News for These Stocks. -- Barrons.com

2 aug. 2024, 17:52 UTC

Achiziții, Fuziuni, Preluări

Hims & Hers Plan to Sell Knockoff Weight Loss Drug Looking Shaky -- Barrons.com

26 iun. 2024, 11:00 UTC

Top știri
Achiziții, Fuziuni, Preluări

The War Over Cheaper Ozempic Won't End Well for Some Investors -- Heard on the Street -- WSJ

24 mai 2024, 20:37 UTC

Câștiguri

The Score: Target, Nvidia, Live Nation and More Stocks That Defined the Week -- WSJ

Comparație

Modificare preț

Hims & Hers Health Inc Așteptări

Obiectiv de preț

By TipRanks

-25.56% jos

Prognoză pe 12 luni

Medie 45.5 USD  -25.56%

Maxim 85 USD

Minim 25 USD

În baza a 14 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruHims & Hers Health Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

14 ratings

4

Cumpărare

8

Păstrare

2

Vânzare

Scor tehnic

By Trading Central

36.685 / 52.35Suport & Rezistență

Termen scurt

Bullish Evidence

Termen mediu

Bullish Evidence

Termen lung

Bullish Evidence

Sentiment

By Acuity

16 / 151 Clasament în Consumator defensiv

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Hims & Hers Health Inc

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.